Glucagon-Like Peptide-1 Receptor Agonists and Atrial Fibrillation Recurrence After Ablation: A Fire Without the Smoke?
JACC Clin Electrophysiol
.
2024 Aug;10(8):1940-1941.
doi: 10.1016/j.jacep.2024.07.004.
Authors
Paschalis Karakasis
1
,
Dimitrios Patoulias
2
,
Stylianos Tzeis
3
,
Nikolaos Fragakis
2
Affiliations
1
Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece. Electronic address:
[email protected]
.
2
Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece.
3
Mitera Hospital, Athens, Greece.
PMID:
39197973
DOI:
10.1016/j.jacep.2024.07.004
No abstract available
Publication types
Editorial
Letter
MeSH terms
Atrial Fibrillation* / drug therapy
Atrial Fibrillation* / surgery
Catheter Ablation*
Glucagon-Like Peptide-1 Receptor Agonists*
Humans
Recurrence*
Substances
Glucagon-Like Peptide-1 Receptor Agonists